Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan

References

• Karassa FB, Ioannidis JP. Mortality in systemic sclerosis. Clin Exp Rheumatol 2008;26:S85–93.
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, . Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005;118:2–10.
   PubMed Web of Science ®Google Scholar
• Kuo CF, See LC, Yu KH, Chou IJ, Tseng WY, Chang HC, . Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 2011, [Epub ahead of print], doi:10.3109/03009742.2011.553736.
   Google Scholar
• Lee P, Alderdice C, Wilkinson S, Keystone EC, Urowitz MB, Gladman DD. Malignancy in progressive systemic sclerosis: association with breast carcinoma. J Rheumatol 1983;10:665–6.
   PubMed Web of Science ®Google Scholar
• Roumm AD, Medsger TA Jr. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 1985;28:1336–40.
   PubMed Web of Science ®Google Scholar
• Young R, Towbin B, Isern R. Scleroderma and ovarian carcinoma. Br J Rheumatol 1990;29:314.
   PubMedGoogle Scholar
• Peters-Golden M, Wise RA, Hochberg M, Stevens MB, Wigley FM. Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985;12:1136–9.
   PubMed Web of Science ®Google Scholar
• Wooten M. Systemic sclerosis and malignancy: a review of the literature. South Med J 2008;101:59–62.
   PubMed Web of Science ®Google Scholar
• Rosenthal AK, McLaughlin JK, Gridley G, Nyren O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995;765:910–14.
   Google Scholar
• Rosenthal AK, McLaughlin JK, Linet MS, Persson I. Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 1993;52:531–3.
   PubMed Web of Science ®Google Scholar
• Olesen AB, Svaerke C, Farkas DK, Sorensen HT. Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study. Br J Dermatol 2010;163:800–6.
   PubMed Web of Science ®Google Scholar
• Kanaji N, Fujita J, Bandoh S, Fukumoto T, Ishikawa M, Haba R, . Small cell lung cancer associated with systemic sclerosis. Intern Med 2005;44:315–18.
   PubMed Web of Science ®Google Scholar
• Scope A, Sadetzki S, Sidi Y, Barzilai A, Trau H, Kaufman B, . Breast cancer and scleroderma. SKINmed 2006;5:18–24.
   PubMedGoogle Scholar
• Pineda V, Salvador R, Soriano J. Bilateral breast cancer associated with diffuse scleroderma. Breast 2003;12:217–19.
   PubMed Web of Science ®Google Scholar
• Siau K, Laversuch CJ, Creamer P, O’Rourke KP. Malignancy in scleroderma patients from South West England: a population-based cohort study. Rheumatol Int 2011;31:641–5.
   PubMed Web of Science ®Google Scholar
• Shah AA, Rosen A, Hummers L, Wigley F, Casciola-Rosen L. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. Arthritis Rheum 2010;62:2787–95.
   PubMed Web of Science ®Google Scholar
• Derk CT, Rasheed M, Artlett CM, Jimenez SA. A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 2006;33:1113–16.
   PubMed Web of Science ®Google Scholar
• Hill CL, Nguyen AM, Roder D, Roberts-Thomson P. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003;62:728–31.
   PubMed Web of Science ®Google Scholar
• Hudson M, Thombs B, Baron M. Time to diagnosis in systemic sclerosis: is sex a factor? Arthritis Rheum 2009;61:274–8.
   PubMed Web of Science ®Google Scholar
• Kang KY, Yim HW, Kim IJ, Yoon JU, Ju JH, Kim HY, . Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre. Scand J Rheumatol 2009;38:299–303.
   PubMed Web of Science ®Google Scholar
• Derk CT, Sakkas LI, Rasheed M, Artlett C, Jimenez SA. Autoantibodies in patients with systemic sclerosis and cancer: a case-control study. J Rheumatol 2003;30:1994–6.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Dombi GW, Severson RK, Mayes MD. Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 2005;52:2415–24.
   PubMed Web of Science ®Google Scholar
• Derk CT, Rasheed M, Spiegel JR, Jimenez SA. Increased incidence of carcinoma of the tongue in patients with systemic sclerosis. J Rheumatol 2005;32:637–41.
   PubMed Web of Science ®Google Scholar
• Harrison BJ, Silman AJ, Hider SL, Herrick AL. Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis. Arthritis Rheum 2002;46:3312–16.
   PubMed Web of Science ®Google Scholar
• Hudson M, Lo E, Lu Y, Hercz D, Baron M, Steele R; Canadian Scleroderma Research Group. Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum 2010;63:230–8.
   Google Scholar
• Derk CT. Associations of breast cancer development in patients with systemic sclerosis: an exploratory study. Clin Rheumatol 2007;26:1615–19.
   PubMed Web of Science ®Google Scholar
• Launay D, Le Berre R, Hatron PY, Peyrat JP, Hachulla E, Devulder B, . Association between systemic sclerosis and breast cancer: eight new cases and review of the literature. Clin Rheumatol 2004;23:516–22.
   PubMed Web of Science ®Google Scholar
• Lu TY, Hill CL, Pontifex EK, Roberts-Thomson PJ. Breast cancer and systemic sclerosis: a clinical description of 21 patients in a population-based cohort study. Rheumatol Int 2008;28:895–9.
   PubMed Web of Science ®Google Scholar
• Silman AJ. Scleroderma – demographics and survival. J Rheumatol Suppl 1997;48:58–61.
   PubMedGoogle Scholar
• Czirjak L, Kumanovics G, Varju C, Nagy Z, Pakozdi A, Szekanecz Z, . Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008;67:59–63.
   PubMed Web of Science ®Google Scholar
• Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, . Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002;81:154–67.
   PubMed Web of Science ®Google Scholar
• Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18:301–7.
   PubMed Web of Science ®Google Scholar